New patent for Catalyst Pharms drug FYCOMPA
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Catalyst Pharms and is included in two NDAs. It is available from two suppliers. There are two patents…
Source
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Catalyst Pharms and is included in two NDAs. It is available from two suppliers. There are two patents…
Source
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for…
Source
Get new actionable insights and updates from BiotechBlog